These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 754770
1. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects]. Cherchi A, Raffo M, Sau F, Seguro C, Pirisi R. Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770 [No Abstract] [Full Text] [Related]
2. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris]. Cherchi A, Fonzo R, Lai C, Mercuro G. Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022 [No Abstract] [Full Text] [Related]
3. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin. Buch J, Rasmussen S. Cor Vasa; 1983; 25(5):358-66. PubMed ID: 6653128 [Abstract] [Full Text] [Related]
4. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension. la Cour Petersen E, Kristensen BO. Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345 [Abstract] [Full Text] [Related]
5. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise. Koch G. Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950 [Abstract] [Full Text] [Related]
6. [Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol]. Rossi A, Ziacchi V, Lomanto B. Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1240-6. PubMed ID: 121529 [Abstract] [Full Text] [Related]
7. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients. Besterman EM, Spencer M. Br J Clin Pharmacol; 1979 Nov; 8(Suppl 2):205S-209S. PubMed ID: 526402 [Abstract] [Full Text] [Related]
8. A comparison and an investigation of a potential synergistic effect of labetalol and bethanidine in patients with mild hypertension. Chalmers AG, Hunter J, Lees CD, Millar JA, Brown JJ, Robertson JI. Br J Clin Pharmacol; 1979 Nov; 8(Suppl 2):183S-187S. PubMed ID: 526399 [Abstract] [Full Text] [Related]
9. [Cardiovascular effects of acute administration of labetalol in hypertensive patients]. Novo S, Pinto A, Davì G, Riolo F, Gullotti D. Boll Soc Ital Cardiol; 1980 Nov; 25(2):149-56. PubMed ID: 7016144 [No Abstract] [Full Text] [Related]
10. Effect of labetalol in hypertension during exercise and postural changes. Balasubramanian V, Mann S, Millar-Craig MW, Raftery EB. Br J Clin Pharmacol; 1979 Nov; 8(Suppl 2):95S-100S. PubMed ID: 526410 [Abstract] [Full Text] [Related]
11. [Hypotensive effect and changes of arterial pressure variability induced by treatment with labetalol in patients with slight and moderate arterial hypertension]. Palatini P, Pessina AC, Sperti G, Ventura E, Agnoletto V, Semplicini A, Hlede M, Gava R, Mormino P, Dal Palù C. G Ital Cardiol; 1983 Nov; 13(1):18-22. PubMed ID: 6873535 [Abstract] [Full Text] [Related]
13. Effect of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension. Pedersen EB, Larsen JS. Postgrad Med J; 1980 Aug; 56 Suppl 2():27-32. PubMed ID: 7433339 [Abstract] [Full Text] [Related]
14. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol. Belogi M, Ansuini R, Pupita G, Campolucci G, Pupita F. Int J Clin Pharmacol Res; 1984 Aug; 4(5):385-7. PubMed ID: 6519853 [Abstract] [Full Text] [Related]
15. [Changes in rest and exercise hemodynamics during long term therapy with a combination alpha and beta blocker in essential hypertension]. Koch G. Verh Dtsch Ges Kreislaufforsch; 1977 Aug; 43():219-20. PubMed ID: 349925 [No Abstract] [Full Text] [Related]
16. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment. Sanders GL, Murray A, Rawlins MD. Br J Clin Pharmacol; 1979 Aug; 8(Suppl 2):125S-127S. PubMed ID: 43163 [Abstract] [Full Text] [Related]
17. Long-term treatment of hypertension with labetalol. Prichard BN, Boakes AJ, Hernández R. Br J Clin Pharmacol; 1979 Aug; 8(Suppl 2):171S-177S. PubMed ID: 526398 [Abstract] [Full Text] [Related]
18. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension. Svendsen TL, Rasmussen S, Hartling OJ, Nielsen PE, Trap-Jensen J. Postgrad Med J; 1980 Aug; 56 Suppl 2():21-6. PubMed ID: 7433338 [Abstract] [Full Text] [Related]